Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

INTRODUCTION: The PRONTO-T1D study, which evaluated the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes (T1D), met the primary endpoint of noninferiority of HbA1c change from baseline compared to lispro at 26 weeks. We present results of an additional 26...

Descripción completa

Detalles Bibliográficos
Autores principales: Bue-Valleskey, Juliana, Klaff, Leslie, Cho, Jang Ik, Dellva, Mary Anne, Schloot, Nanette C., Tobian, Janet, Miura, Junnosuke, Dahl, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846637/
https://www.ncbi.nlm.nih.gov/pubmed/33458803
http://dx.doi.org/10.1007/s13300-020-00987-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846637/
https://www.ncbi.nlm.nih.gov/pubmed/33458803
http://dx.doi.org/10.1007/s13300-020-00987-8

Ejemplares similares